These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15648441)

  • 1. Effects of long-term cyclosporine A therapy on renal functions in Behçet's disease.
    Saricaoglu H; Bulbul EB; Cikman ST; Dilek K; Tunali S
    Int J Tissue React; 2004; 26(3-4):93-6. PubMed ID: 15648441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions].
    Sakane T; Mochizuki M; Inaba G; Masuda K
    Ryumachi; 1995 Oct; 35(5):802-13. PubMed ID: 8594659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and acute renal effects of oral microemulsion ciclosporin A in normal pigs.
    Cibulskyte D; Pedersen M; Hjelm-Poulsen J; Hansen HE; Madsen M; Mortensen J
    Int Immunopharmacol; 2006 Apr; 6(4):627-34. PubMed ID: 16504926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
    Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal outcome after ciclosporin-induced nephrotoxicity.
    Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI
    Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
    Carstens J
    Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
    Schweiger M; Wasler A; Prenner G; Stiegler P; Stadlbauer V; Schwarz M; Tscheliessnigg K
    Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of Behçet's disease.
    Kötter I; Dürk H; Saal J; Fierlbeck G; Pleyer U; Ziehut M
    Ger J Ophthalmol; 1996 Mar; 5(2):92-7. PubMed ID: 8741153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term therapy with low dose cyclosporin A in ocular Behçet's disease.
    Ozdal PC; Ortaç S; Taskintuna I; Firat E
    Doc Ophthalmol; 2002 Nov; 105(3):301-12. PubMed ID: 12539855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant.
    Mourad G; Karras A; Kamar N; Garrigue V; Legendre C; Lefrançois N; Charpentier B; Bourbigot B; Pouteil-Noble C; Bayle F; Lebranchu Y; Mariat C; Le Meur Y; Kessler M; Moulin B; Ducloux D; Delahousse M; Lang P; Merville P; Chaouche-Teyara K; Rostaing L;
    Clin Transplant; 2007; 21(3):295-300. PubMed ID: 17488375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM; Campistol JM; Kreis H; Mourad G; Eris J; Schena FP; Grinyo JM; Nanni G; Andres A; Castaing N; Brault Y; Burke JT
    Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of different dosages of cyclosporine A on the semen parameters of renal transplant patients].
    Xu LG; Xu HM; Zhang JR; Song QZ; Qi XP; Wang XH
    Zhonghua Nan Ke Xue; 2003 Dec; 9(9):679-80, 683. PubMed ID: 14727357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.
    Svenson K; Bohman SO; Hällgren R
    Arch Intern Med; 1986 Oct; 146(10):2007-10. PubMed ID: 3767545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.